NAFLD in children: new genes, new diagnostic modalities and new drugs

Luca Miele, Valerio Nobili, Anna Alisi, Luca Valenti, Ariel E. Feldstein, Naim Alkhouri

Risultato della ricerca: Contributo in rivistaArticolo in rivista

44 Citazioni (Scopus)

Abstract

Nonalcoholic fatty liver disease (NAFLD) has rapidly become the most common form of chronic liver disease in children and adolescents. Over the past 5 years, developments have revolutionized our understanding of the genetic factors, natural history, diagnostic modalities and therapeutic targets for this disease. New polymorphisms, such as those in PNPLA3, TM6SF2, MBOAT7 and GCKR, have been identified and used to predict the development and severity of NAFLD in both adults and children, and their interaction with environmental factors has been elucidated. Studies have demonstrated the true burden of paediatric NAFLD and its progression to end-stage liver disease in adulthood. In particular, nonalcoholic steatohepatitis can progress to advanced fibrosis and cirrhosis, emphasizing the importance of early diagnosis. Non-invasive imaging tests, such as transient elastography, will probably replace liver biopsy for the diagnosis of nonalcoholic steatohepatitis and the assessment of fibrosis severity in the near future. The therapeutic landscape is also expanding rapidly with the development of drugs that can modify liver steatosis, inflammation and fibrosis, indicating that pharnnacotherapy for NAFLD will become available in the future. In this Review, we summarize current knowledge and new advances related to the pathogenesis and management of paediatric NAFLD.
Lingua originaleEnglish
pagine (da-a)517-530
Numero di pagine14
RivistaNATURE REVIEWS. GASTROENTEROLOGY & HEPATOLOGY
Volume16
DOI
Stato di pubblicazionePubblicato - 2019

Keywords

  • Child
  • Humans
  • Non-alcoholic Fatty Liver Disease
  • Risk Factors

Fingerprint Entra nei temi di ricerca di 'NAFLD in children: new genes, new diagnostic modalities and new drugs'. Insieme formano una fingerprint unica.

Cita questo